Other validated targets for miR‐424 include cdc25, a component required to move through the cell cycle and apoptosis inhibitor 49, 50, and bcl‐2, an anti‐apoptotic protein upregulated in several cancers 51, 52. The gene discussed is BCL2; the disease is cancer.